Literature DB >> 18463440

Current guidelines for dyspepsia management.

Alexander C Ford1, Paul Moayyedi.   

Abstract

BACKGROUND: Dyspepsia is a global problem and the management of the condition remains a considerable burden on health care resources. Many countries have adopted evidence-based guidelines for the management of the condition, in an attempt to reduce health care expenditure. This article compares and contrasts dyspepsia management guidelines from several geographical regions.
METHODS: We obtained current guidelines from five regions and examined composition of guideline development groups, methodology involved, definition of dyspepsia utilized, and recommendations in terms of first-line approach, age cutoff for prompt upper gastrointestinal (GI) endoscopy, and subsequent role of endoscopy.
RESULTS: All guidelines carried out extensive reviews of the literature to inform their recommendations. The majority used a definition of dyspepsia in line with the Rome criteria. All agreed that alarm symptoms at any age warranted prompt endoscopy, and most recommended an age cutoff of between 50 and 55 years for endoscopy as an initial management strategy. In young patients without alarm symptoms, either 'test and treat' or empirical acid suppression were the initial management strategies of choice in all cases, with only one guideline recommending mandatory endoscopy in those whose symptoms failed to settle after this approach.
CONCLUSIONS: Despite varying composition of guideline development groups and the different geographical regions, the recommendation of all the guidelines were remarkably similar, reflecting the quality of research conducted by the GI community as a whole. Copyright 2008 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18463440     DOI: 10.1159/000121351

Source DB:  PubMed          Journal:  Dig Dis        ISSN: 0257-2753            Impact factor:   2.404


  8 in total

1.  Performance of American Society for Gastrointestinal Endoscopy guidelines for dyspepsia in Saudi population: prospective observational study.

Authors:  Nahla A Azzam; Majid A Almadi; Hessah Hamad Alamar; Lamis Atyah Almalki; Rehab Nawaf Alrashedi; Rawabi Saleh Alghamdi; Waleed Al-hamoudi
Journal:  World J Gastroenterol       Date:  2015-01-14       Impact factor: 5.742

Review 2.  Clinical practice: diagnosis and evaluation of dyspepsia.

Authors:  David Yates Graham; Massimo Rugge
Journal:  J Clin Gastroenterol       Date:  2010-03       Impact factor: 3.062

3.  A comparison amongst three rapid urease tests to diagnose Helicobacter pylori infection in 375 consecutive dyspeptic.

Authors:  Dino Vaira; Luigi Gatta; Chiara Ricci; Federico Perna; Ilaria Saracino; Giulia Fiorini; Valentina Castelli; John Holton
Journal:  Intern Emerg Med       Date:  2010-02       Impact factor: 3.397

Review 4.  Medical versus surgical treatment for refractory or recurrent peptic ulcer.

Authors:  Kurinchi Selvan Gurusamy; Elena Pallari
Journal:  Cochrane Database Syst Rev       Date:  2016-03-29

5.  Efficacy of omeprazole, famotidine, mosapride and teprenone in patients with upper gastrointestinal symptoms: an omeprazole-controlled randomized study (J-FOCUS).

Authors:  Kouichi Sakurai; Akihito Nagahara; Kazuhiko Inoue; Junichi Akiyama; Katsuhiro Mabe; Junichi Suzuki; Yasuki Habu; Akihiro Araki; Tsuyoshi Suzuki; Katsuaki Satoh; Haruhiko Nagami; Ryosaku Harada; Nobuo Tano; Masayasu Kusaka; Yasuhiko Fujioka; Toshikatsu Fujimura; Nobuyuki Shigeto; Tsuneyo Oumi; Jun Miwa; Hiroto Miwa; Kazuma Fujimoto; Yoshikazu Kinoshita; Ken Haruma
Journal:  BMC Gastroenterol       Date:  2012-05-01       Impact factor: 3.067

6.  Diagnostic accuracy of age and alarm symptoms for upper GI malignancy in patients with dyspepsia in a GI clinic: a 7-year cross-sectional study.

Authors:  Hooman Khademi; Amir-Reza Radmard; Fatemeh Malekzadeh; Farin Kamangar; Siavosh Nasseri-Moghaddam; Mattias Johansson; Graham Byrnes; Paul Brennan; Reza Malekzadeh
Journal:  PLoS One       Date:  2012-06-13       Impact factor: 3.240

7.  Quantitative Platelet Abnormalities in Patients With Hepatitis B Virus-Related Liver Disease.

Authors:  Sylvester Chuks Nwokediuko; Obike Ibegbulam
Journal:  Gastroenterology Res       Date:  2009-11-20

8.  Diagnostic value of alarm symptoms for upper GI malignancy in patients referred to GI clinic: A 7 years cross sectional study.

Authors:  Mohammad Hasan Emami; Masoud Ataie-Khorasgani; Nasim Jafari-Pozve
Journal:  J Res Med Sci       Date:  2017-06-21       Impact factor: 1.852

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.